Detalles de la búsqueda
1.
It is not always chlorhexidine: Identification of benzoxonium chloride and lauramine oxide as culprit allergens in a popular antiseptic in Switzerland.
Contact Dermatitis
; 89(4): 284-289, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286188
2.
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
Cancer Immunol Immunother
; 69(12): 2589-2598, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591862
3.
Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.
J Transl Med
; 17(1): 303, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488153
4.
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
J Eur Acad Dermatol Venereol
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421043
5.
Allergic contact dermatitis from a skin-calming cream containing hydroxyphenyl propamidobenzoic acid.
Contact Dermatitis
; 88(1): 68-70, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094658
6.
Allergic contact dermatitis from pentylene glycol in 'hypoallergenic' eye cosmetics.
Contact Dermatitis
; 88(1): 73-75, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125394
7.
Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial.
Lancet Oncol
; 18(4): 464-472, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28268064
8.
Allergic contact dermatitis from pantolactone and dexpanthenol in wound healing creams.
Contact Dermatitis
; 87(5): 468-471, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946606
9.
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.
J Transl Med
; 14: 95, 2016 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27095081
10.
Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
J Transl Med
; 14(1): 232, 2016 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27484791
11.
Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial.
Cancers (Basel)
; 14(3)2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158952
12.
Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse.
Cancers (Basel)
; 13(3)2021 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33503861
13.
A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab.
Cancers (Basel)
; 13(2)2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33418936
14.
Pembrolizumab for the treatment of uveal melanoma: A case series.
Rare Tumors
; 12: 2036361320971983, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33240475
15.
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma.
JCO Precis Oncol
; 32020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914028
16.
Anaphylaxis-like reaction to anti-BRAF inhibitor dabrafenib confirmed by drug provocation test.
Melanoma Res
; 29(1): 95-98, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30383722
17.
Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma.
Int J Radiat Oncol Biol Phys
; 104(4): 828-835, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30951807
18.
Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases.
ESMO Open
; 4(2): e000464, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962963
19.
Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma.
Melanoma Res
; 29(1): 85-88, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30211812
20.
Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.
Melanoma Res
; 28(1): 65-70, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29227333